The UK government’s Covid-19 Vaccine Taskforce and the contract research company Open Orphan announced a $13 million (£10 million) plan to test investigational vaccines in volunteers who are then intentionally exposed to SARS-CoV-2, the virus that causes Covid-19.
The U.S. health regulator’s criteria for allowing emergency use of a Covid-19 vaccine and plans to monitor its safety after a regulatory go-ahead are among the topics to be discussed at a closely watched meeting.
Pfizer Inc. and BioNTech SE announced the start in Japan of combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against the novel coronavirus.
Moderna Inc. Chief Executive Officer Stéphane Bancel expects interim results from the company’s Covid-19 vaccine trial in November and that the U.S government could give an emergency use nod in December, the Wall Street Journal reported.
Johns Hopkins Scientists Discover Possible Key to Controlling Covid-19 Immune Response
Biological, Blood, Cells, Coronavirus Disease 2019 (COVID-19), Factor D Protein, Immune System, Inflammation, Johns Hopkins University School of Medicine, Membranes, R&D, Researchers, SARS-CoV-2 spike protein, Sugar MoleculesResearchers at Johns Hopkins Medicine identified a protein – known as factor D – that appears essential to the inflammatory process of SARS-CoV-2, the virus that causes Covid-19.
Roche’s Venclexta Granted Full Approval Under Project Orbis and Real-Time Review
Accelerated Approval, Acute Myeloid Leukemia (AML), Adults 75 or older, Approvals, B-cell lymphoma-2 (BCL-2) protein, Chemotherapy, Clinical Trials, FDA/Regulatory, Full Approval, Project Orbis, R&D, Real-Time Oncology Review (RTOR) PilotThe U.S. Food and Drug Administration granted Roche’s Venclexta (venetoclax) full approval in combination with azacytidine, or decitabine, or low-dose cytarabine for newly diagnosed acute myeloid leukemia in adults 75 years or older.
Beckman Coulter will be using a grant from BARDA (the Biomedical Advanced Research and Development Authority, a division of the Dept. of Health and Human Services) to validate the ability of the company’s Monocyte Distribution Width (MDW) hematology biomarker to aid in the rapid detection of a rare but serious complication of Covid-19 affecting children.
Hospitalized Covid-19 patients can have ongoing symptoms for months
Anxiety, Clinical Studies, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Depression, Fatigue, Hospitalized COVID-19 Patients, National Institute for Health Research (NIHR) (UK), Organs, Oxford University, R&D, ScientistsMore than half of Covid-19 patients discharged from hospitals still experienced symptoms of breathlessness, fatigue, anxiety and depression for two to three months after their initial infection, according to the findings of a small UK study.
Many experts are convinced that Covid-19 can trigger the onset of diabetes – even in some adults and children who do not have the traditional risk factors.
German biotech company Evotec said on Monday the company had received a grant from the Bill & Melinda Gates Foundation to help identify and develop potential monoclonal antibody (mAbS) drugs for the prevention of severe Covid-19.